Venture Capital

Insight into TransCode Therapeutics' (RNAZ) $29 Million IPO Effort


TransCode Therapeutics (RNAZ) has filed to raise $29 million in an IPO. The firm is developing treatments for metastatic cancer. An insight into the …

Read more

Show More

Related Articles

Back to top button